• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食物对噻奈普汀及其主要代谢物动力学的影响。

Influence of food on tianeptine and its main metabolite kinetics.

作者信息

Dresse A, Rosen J M, Brems H, Masset H, Defrance R, Salvadori C

机构信息

Laboratoire de Pharmacologie, Université de Liège, Belgium.

出版信息

J Clin Pharmacol. 1988 Dec;28(12):1115-9. doi: 10.1002/j.1552-4604.1988.tb05726.x.

DOI:10.1002/j.1552-4604.1988.tb05726.x
PMID:3243929
Abstract

The influence of a test meal on the absorption and disposition of tianeptine (Stablon), a new antidepressant, was investigated in 12 healthy subjects in a two-way, randomized, open cross-over study. Single 12.5-mg oral doses of tianeptine were administered following a night of fasting or immediately after a standardized breakfast. When subjects received tianeptine under fasting conditions the lag time before absorption onset, and the time of the maximum plasma concentration were 0.55 +/- 0.26 hours and 1.29 +/- 0.29 hours, respectively. The maximum plasma concentration was 322 +/- 44 ng/mL, and the total area under the curve 994 +/- 248 ng/hr/mL. When tianeptine was given at the end of the meal, several significant changes were found for tianeptine kinetic parameters; the lag time increased by 0.3 hour and the maximum plasma concentration was lowered (decreased by 25%) and occurred later (tmax increased by 0.5 hour). However, no significant change was found in the area under the plasma concentration-time curve. The trend and extent of changes in the MC5 metabolite parameters were similar to those observed for the parent drug. Absorption of tianeptine is slightly delayed and slowed down without modification of its extent when tianeptine is given at the end of a meal. These slight changes are not clinically relevant for an antidepressant administered three times a day. Despite the changes observed, tianeptine may be given at meal times to improve compliance with treatment.

摘要

在一项双向、随机、开放交叉研究中,对12名健康受试者研究了试验餐对新型抗抑郁药噻奈普汀(Stablon)吸收和处置的影响。在禁食一夜后或在标准早餐后立即给予单次12.5mg口服噻奈普汀剂量。当受试者在禁食条件下接受噻奈普汀时,吸收开始前的滞后时间和血浆最大浓度时间分别为0.55±0.26小时和1.29±0.29小时。血浆最大浓度为322±44ng/mL,曲线下总面积为994±248ng/hr/mL。当在进餐结束时给予噻奈普汀时,发现噻奈普汀动力学参数有几个显著变化;滞后时间增加了0.3小时,血浆最大浓度降低(下降25%)且出现时间延迟(tmax增加0.5小时)。然而,血浆浓度-时间曲线下面积未发现显著变化。MC5代谢物参数的变化趋势和程度与母体药物观察到的相似。当在进餐结束时给予噻奈普汀时,其吸收略有延迟且减慢,但其吸收程度未改变。这些轻微变化对于每日给药三次的抗抑郁药而言在临床上不相关。尽管观察到有变化,但噻奈普汀可在进餐时给药以提高治疗依从性。

相似文献

1
Influence of food on tianeptine and its main metabolite kinetics.食物对噻奈普汀及其主要代谢物动力学的影响。
J Clin Pharmacol. 1988 Dec;28(12):1115-9. doi: 10.1002/j.1552-4604.1988.tb05726.x.
2
The pharmacokinetics of the antidepressant tianeptine and its main metabolite in healthy humans--influence of alcohol co-administration.抗抑郁药噻奈普汀及其主要代谢产物在健康人体内的药代动力学——酒精共同给药的影响
Fundam Clin Pharmacol. 1990;4(1):115-25. doi: 10.1111/j.1472-8206.1990.tb01021.x.
3
Tianeptine and its main metabolite. Disposition in chronic renal failure and haemodialysis.噻奈普汀及其主要代谢产物。在慢性肾衰竭和血液透析中的处置情况。
Fundam Clin Pharmacol. 1990;4(6):663-71. doi: 10.1111/j.1472-8206.1990.tb00046.x.
4
Pharmacokinetics of the antidepressant tianeptine at steady state in the elderly.抗抑郁药噻奈普汀在老年人稳态时的药代动力学
J Clin Pharmacol. 1991 Feb;31(2):174-8. doi: 10.1002/j.1552-4604.1991.tb03703.x.
5
Tianeptine and its main metabolite pharmacokinetics in chronic alcoholism and cirrhosis.噻奈普汀及其主要代谢产物在慢性酒精中毒和肝硬化中的药代动力学
Clin Pharmacokinet. 1989 Mar;16(3):186-91. doi: 10.2165/00003088-198916030-00005.
6
Pharmacokinetic and metabolic parameters of tianeptine in healthy volunteers and in populations with risk factors.噻奈普汀在健康志愿者及有风险因素人群中的药代动力学和代谢参数。
Clin Neuropharmacol. 1988;11 Suppl 2:S90-6.
7
Pharmacokinetic study of tianeptine and its active metabolite MC5 in rats following different routes of administration using a novel liquid chromatography tandem mass spectrometry analytical method.采用新型液相色谱串联质谱分析方法研究不同给药途径下硫醚哌嗪及其中间代谢产物 MC5 在大鼠体内的药代动力学。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Feb;391(2):185-196. doi: 10.1007/s00210-017-1448-2. Epub 2017 Dec 12.
8
The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers.新型抗抑郁药噻奈普汀在健康志愿者体内的代谢途径。
Drug Metab Dispos. 1990 Sep-Oct;18(5):804-8.
9
Pharmacokinetic and bioequivalence assessment of two formulations of tianeptine sodium in healthy male volunteers.健康男性志愿者中两种硫蒽酮钠制剂的药代动力学和生物等效性评估。
Int J Clin Pharmacol Ther. 2014 Sep;52(9):817-23. doi: 10.5414/cp202128.
10
The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.抗抑郁药噻奈普汀的行为效应需要μ-阿片受体。
Neuropsychopharmacology. 2017 Sep;42(10):2052-2063. doi: 10.1038/npp.2017.60. Epub 2017 Mar 17.

引用本文的文献

1
An Outbreak of Synthetic Cannabinoid-Adulterated Tianeptine Products in New Jersey - Case Series.新泽西州合成大麻素掺杂替奈普汀产品的暴发——病例系列
J Med Toxicol. 2025 Apr;21(2):253-259. doi: 10.1007/s13181-025-01068-7. Epub 2025 Mar 18.
2
Classics in Chemical Neuroscience: Tianeptine.化学神经科学经典:噻奈普汀。
ACS Chem Neurosci. 2024 Nov 6;15(21):3863-3873. doi: 10.1021/acschemneuro.4c00519. Epub 2024 Oct 9.
3
In Vitro-In Vivo Correlation of Tianeptine Sodium Sustained-Release Dual-Layer Tablets.替奈普汀钠双层缓释片的体外-体内相关性研究。
Molecules. 2022 Apr 29;27(9):2828. doi: 10.3390/molecules27092828.
4
Notes from the Field: Toxic Leukoencephalopathy Associated with Tianeptine Misuse - California, 2017.实地记录:与噻奈普汀滥用相关的中毒性白质脑病——加利福尼亚州,2017年
MMWR Morb Mortal Wkly Rep. 2018 Jul 13;67(27):769-770. doi: 10.15585/mmwr.mm6727a5.
5
Tianeptine: a review of its use in depressive disorders.噻奈普汀:用于抑郁症治疗的综述
CNS Drugs. 2001;15(3):231-59. doi: 10.2165/00023210-200115030-00006.
6
Effects of food on clinical pharmacokinetics.食物对临床药代动力学的影响。
Clin Pharmacokinet. 1999 Sep;37(3):213-55. doi: 10.2165/00003088-199937030-00003.
7
Development of a population pharmacokinetic database for tianeptine.噻奈普汀群体药代动力学数据库的建立。
Eur J Clin Pharmacol. 1993;45(2):173-9. doi: 10.1007/BF00315502.
8
Pharmacokinetic optimisation of therapy with newer antidepressants.新型抗抑郁药治疗的药代动力学优化
Clin Pharmacokinet. 1994 Oct;27(4):307-30. doi: 10.2165/00003088-199427040-00005.
9
Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.噻奈普汀。对其药效学、药代动力学特性以及在抑郁症和并存的焦虑症与抑郁症中的治疗效果的综述。
Drugs. 1995 Mar;49(3):411-39. doi: 10.2165/00003495-199549030-00007.